No abstract available
MeSH terms
-
Adalimumab / adverse effects
-
Adalimumab / therapeutic use
-
Age Factors
-
Aged
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Etanercept / adverse effects
-
Etanercept / therapeutic use
-
Female
-
Humans
-
Infliximab / adverse effects
-
Infliximab / therapeutic use
-
Male
-
Middle Aged
-
Psoriasis* / drug therapy
-
Republic of Korea / epidemiology
-
Retrospective Studies
-
Severity of Illness Index
-
Treatment Outcome
Substances
-
Adalimumab
-
Antibodies, Monoclonal, Humanized
-
Etanercept
-
Infliximab